| ENSG00000234139.2 |
Cyclopamine |
Breast invasive carcinoma |
0.049552326 |
Resistant |
| ENSG00000236921.1 |
Cyclopamine |
Breast invasive carcinoma |
0.036773187 |
Resistant |
| ENSG00000237940.3 |
Cyclopamine |
Breast invasive carcinoma |
0.010976243 |
Resistant |
| ENSG00000247095.2 |
Cyclopamine |
Breast invasive carcinoma |
0.023218939 |
Resistant |
| ENSG00000259376.1 |
Cyclopamine |
Breast invasive carcinoma |
0.046974777 |
Resistant |
| ENSG00000260816.1 |
Cyclopamine |
Breast invasive carcinoma |
0.011739082 |
Resistant |
| ENSG00000263400.2 |
Cyclopamine |
Breast invasive carcinoma |
0.021693713 |
Resistant |
| ENSG00000267121.1 |
Cyclopamine |
Breast invasive carcinoma |
0.042696274 |
Resistant |
| ENSG00000272010.1 |
Cyclopamine |
Breast invasive carcinoma |
0.046786149 |
Resistant |
| ENSG00000272508.1 |
Cyclopamine |
Breast invasive carcinoma |
0.043060512 |
Resistant |
| ENSG00000273233.1 |
Cyclopamine |
Breast invasive carcinoma |
0.039125138 |
Resistant |
| ENSG00000213468.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042324476 |
Resistant |
| ENSG00000223573.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049830183 |
Resistant |
| ENSG00000229697.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012540702 |
Resistant |
| ENSG00000230534.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036504043 |
Resistant |
| ENSG00000230896.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014103141 |
Resistant |
| ENSG00000232564.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028094488 |
Resistant |
| ENSG00000236772.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015485487 |
Resistant |
| ENSG00000249787.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024154999 |
Resistant |
| ENSG00000251432.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001395659 |
Resistant |
| ENSG00000258034.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036743029 |
Resistant |
| ENSG00000259187.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007911418 |
Resistant |
| ENSG00000260288.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036784417 |
Resistant |
| ENSG00000261216.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039109357 |
Resistant |
| ENSG00000265334.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038179812 |
Resistant |
| ENSG00000266783.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031832764 |
Resistant |
| ENSG00000266975.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009136632 |
Resistant |
| ENSG00000267798.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008750378 |
Resistant |
| ENSG00000269867.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01455795 |
Resistant |
| ENSG00000269900.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037007393 |
Resistant |
| ENSG00000272576.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047494592 |
Resistant |
| ENSG00000272800.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033732412 |
Resistant |
| ENSG00000215863.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.016116713 |
Resistant |
| ENSG00000223576.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.037224396 |
Resistant |
| ENSG00000223779.4 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.012066514 |
Resistant |
| ENSG00000223791.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.029461186 |
Resistant |
| ENSG00000224356.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.036204215 |
Resistant |
| ENSG00000224638.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.03707282 |
Resistant |
| ENSG00000226137.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.0168882 |
Resistant |
| ENSG00000226367.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.043133675 |
Resistant |
| ENSG00000226637.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019650227 |
Resistant |
| ENSG00000227484.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.029016066 |
Resistant |
| ENSG00000227946.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.039680222 |
Resistant |
| ENSG00000228065.6 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.023761633 |
Resistant |
| ENSG00000228280.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.049822345 |
Resistant |
| ENSG00000228573.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.042316914 |
Resistant |
| ENSG00000228933.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.026198115 |
Resistant |
| ENSG00000229278.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.007704966 |
Resistant |
| ENSG00000229463.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.044038221 |
Resistant |
| ENSG00000229841.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.034137883 |
Resistant |
| ENSG00000229867.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.041371448 |
Resistant |
| ENSG00000229981.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.02381284 |
Resistant |
| ENSG00000232151.5 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.026759394 |
Resistant |
| ENSG00000232259.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.041442042 |
Resistant |
| ENSG00000232586.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.022239593 |
Resistant |
| ENSG00000232721.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.00574082 |
Resistant |
| ENSG00000233058.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019153325 |
Resistant |
| ENSG00000233461.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019829708 |
Resistant |
| ENSG00000235079.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.011905256 |
Resistant |
| ENSG00000235117.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.045124199 |
Resistant |
| ENSG00000235397.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.027510409 |
Resistant |
| ENSG00000235398.4 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.009636541 |
Resistant |
| ENSG00000236269.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.031915325 |
Resistant |
| ENSG00000236643.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.003445765 |
Resistant |
| ENSG00000236943.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.005900977 |
Resistant |
| ENSG00000237301.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.016761836 |
Resistant |
| ENSG00000238266.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.014836431 |
Resistant |
| ENSG00000245552.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.004310824 |
Resistant |
| ENSG00000247624.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019021566 |
Resistant |
| ENSG00000248360.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.046635791 |
Resistant |
| ENSG00000249035.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.018683452 |
Resistant |
| ENSG00000251442.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.022857062 |
Resistant |
| ENSG00000253210.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.01891202 |
Resistant |
| ENSG00000253513.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.01949595 |
Resistant |
| ENSG00000253712.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.024073014 |
Resistant |
| ENSG00000255165.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040848654 |
Resistant |
| ENSG00000255247.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.010335635 |
Resistant |
| ENSG00000257681.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.023158719 |
Resistant |
| ENSG00000257702.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.035149949 |
Resistant |
| ENSG00000258168.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.043571748 |
Resistant |
| ENSG00000259372.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.036208095 |
Resistant |
| ENSG00000260641.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.01079266 |
Resistant |
| ENSG00000261423.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.032942677 |
Resistant |
| ENSG00000261838.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.029535061 |
Resistant |
| ENSG00000263098.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.031192374 |
Resistant |
| ENSG00000263862.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.024688591 |
Resistant |
| ENSG00000264672.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.030320454 |
Resistant |
| ENSG00000265055.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.04772371 |
Resistant |
| ENSG00000265342.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.016798445 |
Resistant |
| ENSG00000266921.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.0442107 |
Resistant |
| ENSG00000267159.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.035403261 |
Resistant |
| ENSG00000267808.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.048282852 |
Resistant |
| ENSG00000269019.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.049304296 |
Resistant |
| ENSG00000269956.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.012651761 |
Resistant |
| ENSG00000270640.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.015136759 |
Resistant |
| ENSG00000272077.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040979582 |
Resistant |
| ENSG00000272908.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.049050238 |
Resistant |
| ENSG00000273129.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.042006727 |
Resistant |
| ENSG00000152487.6 |
Cyclopamine |
Brain lower grade glioma |
0.038521319 |
Resistant |
| ENSG00000179818.9 |
Cyclopamine |
Brain lower grade glioma |
0.012068211 |
Resistant |
| ENSG00000189419.5 |
Cyclopamine |
Brain lower grade glioma |
0.046722966 |
Resistant |
| ENSG00000196951.6 |
Cyclopamine |
Brain lower grade glioma |
0.001525818 |
Resistant |
| ENSG00000204666.3 |
Cyclopamine |
Brain lower grade glioma |
0.038837205 |
Resistant |
| ENSG00000206142.5 |
Cyclopamine |
Brain lower grade glioma |
0.046017867 |
Resistant |
| ENSG00000214725.3 |
Cyclopamine |
Brain lower grade glioma |
0.001129509 |
Resistant |
| ENSG00000214733.4 |
Cyclopamine |
Brain lower grade glioma |
0.039628879 |
Resistant |
| ENSG00000215039.2 |
Cyclopamine |
Brain lower grade glioma |
0.005641355 |
Resistant |
| ENSG00000215458.4 |
Cyclopamine |
Brain lower grade glioma |
0.038284636 |
Resistant |
| ENSG00000218018.2 |
Cyclopamine |
Brain lower grade glioma |
0.040172023 |
Resistant |
| ENSG00000223745.3 |
Cyclopamine |
Brain lower grade glioma |
0.016048642 |
Resistant |
| ENSG00000223960.2 |
Cyclopamine |
Brain lower grade glioma |
0.018046581 |
Resistant |
| ENSG00000224031.1 |
Cyclopamine |
Brain lower grade glioma |
0.010760245 |
Resistant |
| ENSG00000224165.1 |
Cyclopamine |
Brain lower grade glioma |
0.044130249 |
Resistant |
| ENSG00000224358.1 |
Cyclopamine |
Brain lower grade glioma |
0.014720826 |
Resistant |
| ENSG00000224505.2 |
Cyclopamine |
Brain lower grade glioma |
0.011171768 |
Resistant |
| ENSG00000224799.1 |
Cyclopamine |
Brain lower grade glioma |
0.024024972 |
Resistant |
| ENSG00000225152.1 |
Cyclopamine |
Brain lower grade glioma |
0.021163583 |
Resistant |
| ENSG00000225218.1 |
Cyclopamine |
Brain lower grade glioma |
0.017157601 |
Resistant |
| ENSG00000225806.3 |
Cyclopamine |
Brain lower grade glioma |
0.035184127 |
Resistant |
| ENSG00000226471.2 |
Cyclopamine |
Brain lower grade glioma |
0.016655404 |
Resistant |
| ENSG00000227540.1 |
Cyclopamine |
Brain lower grade glioma |
0.000105334 |
Resistant |
| ENSG00000227542.1 |
Cyclopamine |
Brain lower grade glioma |
0.034601717 |
Resistant |
| ENSG00000228802.1 |
Cyclopamine |
Brain lower grade glioma |
0.039773982 |
Resistant |
| ENSG00000229127.1 |
Cyclopamine |
Brain lower grade glioma |
0.003750471 |
Resistant |
| ENSG00000229521.2 |
Cyclopamine |
Brain lower grade glioma |
0.046629686 |
Resistant |
| ENSG00000229582.2 |
Cyclopamine |
Brain lower grade glioma |
0.023046727 |
Resistant |
| ENSG00000229869.1 |
Cyclopamine |
Brain lower grade glioma |
0.021532585 |
Resistant |
| ENSG00000230534.2 |
Cyclopamine |
Brain lower grade glioma |
0.03016758 |
Resistant |
| ENSG00000230612.1 |
Cyclopamine |
Brain lower grade glioma |
0.014324197 |
Resistant |
| ENSG00000230736.2 |
Cyclopamine |
Brain lower grade glioma |
0.046426786 |
Resistant |
| ENSG00000231104.4 |
Cyclopamine |
Brain lower grade glioma |
0.030978309 |
Resistant |
| ENSG00000231393.1 |
Cyclopamine |
Brain lower grade glioma |
0.049329658 |
Resistant |
| ENSG00000231616.4 |
Cyclopamine |
Brain lower grade glioma |
0.046217567 |
Resistant |
| ENSG00000232065.1 |
Cyclopamine |
Brain lower grade glioma |
0.010080037 |
Resistant |
| ENSG00000232645.1 |
Cyclopamine |
Brain lower grade glioma |
0.011736911 |
Resistant |
| ENSG00000232828.1 |
Cyclopamine |
Brain lower grade glioma |
0.032493095 |
Resistant |
| ENSG00000233242.2 |
Cyclopamine |
Brain lower grade glioma |
0.014751519 |
Resistant |
| ENSG00000233246.1 |
Cyclopamine |
Brain lower grade glioma |
0.001402648 |
Resistant |
| ENSG00000233825.1 |
Cyclopamine |
Brain lower grade glioma |
0.042834586 |
Resistant |
| ENSG00000234134.1 |
Cyclopamine |
Brain lower grade glioma |
0.033520493 |
Resistant |
| ENSG00000234183.1 |
Cyclopamine |
Brain lower grade glioma |
0.035023885 |
Resistant |
| ENSG00000234676.1 |
Cyclopamine |
Brain lower grade glioma |
0.039103264 |
Resistant |
| ENSG00000234912.5 |
Cyclopamine |
Brain lower grade glioma |
0.043138813 |
Resistant |
| ENSG00000234978.1 |
Cyclopamine |
Brain lower grade glioma |
0.046044813 |
Resistant |
| ENSG00000235381.1 |
Cyclopamine |
Brain lower grade glioma |
0.036627988 |
Resistant |
| ENSG00000236144.2 |
Cyclopamine |
Brain lower grade glioma |
0.009431267 |
Resistant |
| ENSG00000236519.1 |
Cyclopamine |
Brain lower grade glioma |
0.039194441 |
Resistant |
| ENSG00000236641.1 |
Cyclopamine |
Brain lower grade glioma |
0.040684481 |
Resistant |
| ENSG00000236810.1 |
Cyclopamine |
Brain lower grade glioma |
0.022365942 |
Resistant |
| ENSG00000236824.1 |
Cyclopamine |
Brain lower grade glioma |
0.042434266 |
Resistant |
| ENSG00000236859.2 |
Cyclopamine |
Brain lower grade glioma |
0.017499897 |
Resistant |
| ENSG00000237513.1 |
Cyclopamine |
Brain lower grade glioma |
0.006562083 |
Resistant |
| ENSG00000237899.1 |
Cyclopamine |
Brain lower grade glioma |
0.03274984 |
Resistant |
| ENSG00000237927.1 |
Cyclopamine |
Brain lower grade glioma |
0.020601476 |
Resistant |
| ENSG00000238009.2 |
Cyclopamine |
Brain lower grade glioma |
0.015095555 |
Resistant |
| ENSG00000239945.1 |
Cyclopamine |
Brain lower grade glioma |
0.013956376 |
Resistant |
| ENSG00000241219.1 |
Cyclopamine |
Brain lower grade glioma |
0.034800571 |
Resistant |
| ENSG00000242797.2 |
Cyclopamine |
Brain lower grade glioma |
0.03004036 |
Resistant |
| ENSG00000243224.1 |
Cyclopamine |
Brain lower grade glioma |
0.017381671 |
Resistant |
| ENSG00000243389.1 |
Cyclopamine |
Brain lower grade glioma |
0.041356625 |
Resistant |
| ENSG00000244184.1 |
Cyclopamine |
Brain lower grade glioma |
0.008556747 |
Resistant |
| ENSG00000245685.2 |
Cyclopamine |
Brain lower grade glioma |
0.02201806 |
Resistant |
| ENSG00000245748.1 |
Cyclopamine |
Brain lower grade glioma |
0.001468754 |
Resistant |
| ENSG00000247373.2 |
Cyclopamine |
Brain lower grade glioma |
0.0317005 |
Resistant |
| ENSG00000247950.2 |
Cyclopamine |
Brain lower grade glioma |
0.045906036 |
Resistant |
| ENSG00000248049.2 |
Cyclopamine |
Brain lower grade glioma |
0.025897533 |
Resistant |
| ENSG00000248240.1 |
Cyclopamine |
Brain lower grade glioma |
0.046441649 |
Resistant |
| ENSG00000248243.1 |
Cyclopamine |
Brain lower grade glioma |
0.017542414 |
Resistant |
| ENSG00000248664.1 |
Cyclopamine |
Brain lower grade glioma |
0.008712138 |
Resistant |
| ENSG00000248671.3 |
Cyclopamine |
Brain lower grade glioma |
0.004508628 |
Resistant |
| ENSG00000248758.1 |
Cyclopamine |
Brain lower grade glioma |
0.02976197 |
Resistant |
| ENSG00000248858.3 |
Cyclopamine |
Brain lower grade glioma |
0.046959263 |
Resistant |
| ENSG00000248936.1 |
Cyclopamine |
Brain lower grade glioma |
0.024222184 |
Resistant |
| ENSG00000249207.1 |
Cyclopamine |
Brain lower grade glioma |
0.045441687 |
Resistant |
| ENSG00000249234.1 |
Cyclopamine |
Brain lower grade glioma |
0.002141604 |
Resistant |
| ENSG00000249307.1 |
Cyclopamine |
Brain lower grade glioma |
0.011105178 |
Resistant |
| ENSG00000249417.1 |
Cyclopamine |
Brain lower grade glioma |
0.044050532 |
Resistant |
| ENSG00000249502.1 |
Cyclopamine |
Brain lower grade glioma |
0.049981991 |
Resistant |
| ENSG00000249673.2 |
Cyclopamine |
Brain lower grade glioma |
0.043473711 |
Resistant |
| ENSG00000249753.2 |
Cyclopamine |
Brain lower grade glioma |
0.014429128 |
Resistant |
| ENSG00000250027.1 |
Cyclopamine |
Brain lower grade glioma |
0.035107502 |
Resistant |
| ENSG00000250682.1 |
Cyclopamine |
Brain lower grade glioma |
0.045177503 |
Resistant |
| ENSG00000250899.3 |
Cyclopamine |
Brain lower grade glioma |
0.013187678 |
Resistant |
| ENSG00000251602.2 |
Cyclopamine |
Brain lower grade glioma |
0.026318 |
Resistant |
| ENSG00000253773.1 |
Cyclopamine |
Brain lower grade glioma |
0.041824413 |
Resistant |
| ENSG00000253878.1 |
Cyclopamine |
Brain lower grade glioma |
0.022976813 |
Resistant |
| ENSG00000254266.1 |
Cyclopamine |
Brain lower grade glioma |
0.041569893 |
Resistant |
| ENSG00000254539.1 |
Cyclopamine |
Brain lower grade glioma |
0.042596378 |
Resistant |
| ENSG00000254577.1 |
Cyclopamine |
Brain lower grade glioma |
0.022649455 |
Resistant |
| ENSG00000254604.1 |
Cyclopamine |
Brain lower grade glioma |
0.004135145 |
Resistant |
| ENSG00000254855.1 |
Cyclopamine |
Brain lower grade glioma |
0.014320826 |
Resistant |
| ENSG00000254900.1 |
Cyclopamine |
Brain lower grade glioma |
0.039844043 |
Resistant |
| ENSG00000255741.1 |
Cyclopamine |
Brain lower grade glioma |
0.039143666 |
Resistant |
| ENSG00000256092.2 |
Cyclopamine |
Brain lower grade glioma |
0.030052014 |
Resistant |
| ENSG00000256250.1 |
Cyclopamine |
Brain lower grade glioma |
0.0403345 |
Resistant |
| ENSG00000256897.1 |
Cyclopamine |
Brain lower grade glioma |
0.009477718 |
Resistant |
| ENSG00000257004.1 |
Cyclopamine |
Brain lower grade glioma |
0.014814405 |
Resistant |
| ENSG00000257135.1 |
Cyclopamine |
Brain lower grade glioma |
0.032436519 |
Resistant |
| ENSG00000257176.1 |
Cyclopamine |
Brain lower grade glioma |
0.002562119 |
Resistant |
| ENSG00000257595.2 |
Cyclopamine |
Brain lower grade glioma |
0.003633296 |
Resistant |
| ENSG00000257815.1 |
Cyclopamine |
Brain lower grade glioma |
0.045379222 |
Resistant |
| ENSG00000259172.1 |
Cyclopamine |
Brain lower grade glioma |
0.027326788 |
Resistant |
| ENSG00000259442.1 |
Cyclopamine |
Brain lower grade glioma |
0.047379609 |
Resistant |
| ENSG00000259453.1 |
Cyclopamine |
Brain lower grade glioma |
0.002090305 |
Resistant |
| ENSG00000259583.1 |
Cyclopamine |
Brain lower grade glioma |
0.04099638 |
Resistant |
| ENSG00000259589.2 |
Cyclopamine |
Brain lower grade glioma |
0.047043605 |
Resistant |
| ENSG00000260091.1 |
Cyclopamine |
Brain lower grade glioma |
0.044991965 |
Resistant |
| ENSG00000260269.1 |
Cyclopamine |
Brain lower grade glioma |
0.022256759 |
Resistant |
| ENSG00000260276.1 |
Cyclopamine |
Brain lower grade glioma |
0.031380453 |
Resistant |
| ENSG00000260369.2 |
Cyclopamine |
Brain lower grade glioma |
0.047738008 |
Resistant |
| ENSG00000260388.1 |
Cyclopamine |
Brain lower grade glioma |
0.021371833 |
Resistant |
| ENSG00000260398.1 |
Cyclopamine |
Brain lower grade glioma |
0.038883125 |
Resistant |
| ENSG00000260526.1 |
Cyclopamine |
Brain lower grade glioma |
0.02565541 |
Resistant |
| ENSG00000260923.1 |
Cyclopamine |
Brain lower grade glioma |
0.022355246 |
Resistant |
| ENSG00000261096.1 |
Cyclopamine |
Brain lower grade glioma |
0.011262135 |
Resistant |
| ENSG00000261159.1 |
Cyclopamine |
Brain lower grade glioma |
0.024793964 |
Resistant |
| ENSG00000261838.1 |
Cyclopamine |
Brain lower grade glioma |
0.02764653 |
Resistant |
| ENSG00000262222.1 |
Cyclopamine |
Brain lower grade glioma |
0.000039 |
Resistant |
| ENSG00000262652.1 |
Cyclopamine |
Brain lower grade glioma |
0.007101682 |
Resistant |
| ENSG00000263013.1 |
Cyclopamine |
Brain lower grade glioma |
0.000382676 |
Resistant |
| ENSG00000263350.1 |
Cyclopamine |
Brain lower grade glioma |
0.026486127 |
Resistant |
| ENSG00000263412.1 |
Cyclopamine |
Brain lower grade glioma |
0.047791015 |
Resistant |
| ENSG00000265542.1 |
Cyclopamine |
Brain lower grade glioma |
0.020648359 |
Resistant |
| ENSG00000266040.1 |
Cyclopamine |
Brain lower grade glioma |
0.042102378 |
Resistant |
| ENSG00000266821.1 |
Cyclopamine |
Brain lower grade glioma |
0.048011836 |
Resistant |
| ENSG00000267212.1 |
Cyclopamine |
Brain lower grade glioma |
0.01265516 |
Resistant |
| ENSG00000268340.1 |
Cyclopamine |
Brain lower grade glioma |
0.046067573 |
Resistant |
| ENSG00000268573.1 |
Cyclopamine |
Brain lower grade glioma |
0.013574216 |
Resistant |
| ENSG00000269399.1 |
Cyclopamine |
Brain lower grade glioma |
0.001382297 |
Resistant |
| ENSG00000269653.1 |
Cyclopamine |
Brain lower grade glioma |
0.011522368 |
Resistant |
| ENSG00000269893.2 |
Cyclopamine |
Brain lower grade glioma |
0.000776451 |
Resistant |
| ENSG00000269938.1 |
Cyclopamine |
Brain lower grade glioma |
0.013347082 |
Resistant |
| ENSG00000269942.1 |
Cyclopamine |
Brain lower grade glioma |
0.045024023 |
Resistant |
| ENSG00000269947.1 |
Cyclopamine |
Brain lower grade glioma |
0.044256145 |
Resistant |
| ENSG00000270081.1 |
Cyclopamine |
Brain lower grade glioma |
0.034922476 |
Resistant |
| ENSG00000270091.1 |
Cyclopamine |
Brain lower grade glioma |
0.017353974 |
Resistant |
| ENSG00000270109.1 |
Cyclopamine |
Brain lower grade glioma |
0.003579383 |
Resistant |
| ENSG00000271335.1 |
Cyclopamine |
Brain lower grade glioma |
0.003005273 |
Resistant |
| ENSG00000271347.1 |
Cyclopamine |
Brain lower grade glioma |
0.038319312 |
Resistant |
| ENSG00000271359.1 |
Cyclopamine |
Brain lower grade glioma |
0.041787588 |
Resistant |
| ENSG00000271382.1 |
Cyclopamine |
Brain lower grade glioma |
0.009116566 |
Resistant |
| ENSG00000271911.1 |
Cyclopamine |
Brain lower grade glioma |
0.035734038 |
Resistant |
| ENSG00000271964.1 |
Cyclopamine |
Brain lower grade glioma |
0.013358741 |
Resistant |
| ENSG00000271991.1 |
Cyclopamine |
Brain lower grade glioma |
0.018586379 |
Resistant |
| ENSG00000272143.1 |
Cyclopamine |
Brain lower grade glioma |
0.015975652 |
Resistant |
| ENSG00000272644.1 |
Cyclopamine |
Brain lower grade glioma |
0.017043594 |
Resistant |
| ENSG00000272721.1 |
Cyclopamine |
Brain lower grade glioma |
0.010285554 |
Resistant |
| ENSG00000272754.1 |
Cyclopamine |
Brain lower grade glioma |
0.041221534 |
Resistant |
| ENSG00000272777.1 |
Cyclopamine |
Brain lower grade glioma |
0.046253492 |
Resistant |
| ENSG00000272828.1 |
Cyclopamine |
Brain lower grade glioma |
0.017336361 |
Resistant |
| ENSG00000272995.1 |
Cyclopamine |
Brain lower grade glioma |
0.029170488 |
Resistant |
| ENSG00000273019.1 |
Cyclopamine |
Brain lower grade glioma |
0.03651673 |
Resistant |
| ENSG00000273061.1 |
Cyclopamine |
Brain lower grade glioma |
0.049720368 |
Resistant |
| ENSG00000273290.1 |
Cyclopamine |
Brain lower grade glioma |
0.024062522 |
Resistant |
| ENSG00000273449.1 |
Cyclopamine |
Brain lower grade glioma |
0.007457577 |
Resistant |
| ENSG00000182873.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.004950564 |
Resistant |
| ENSG00000185203.7 |
Cyclopamine |
Lung squamous cell carcinoma |
0.040645378 |
Resistant |
| ENSG00000188424.5 |
Cyclopamine |
Lung squamous cell carcinoma |
0.039219648 |
Resistant |
| ENSG00000196421.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042037322 |
Resistant |
| ENSG00000197291.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.024053086 |
Resistant |
| ENSG00000204832.5 |
Cyclopamine |
Lung squamous cell carcinoma |
0.031546885 |
Resistant |
| ENSG00000204860.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.01172178 |
Resistant |
| ENSG00000223461.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.034187441 |
Resistant |
| ENSG00000223486.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.043448448 |
Resistant |
| ENSG00000223561.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03654524 |
Resistant |
| ENSG00000224090.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045214872 |
Resistant |
| ENSG00000224189.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006574634 |
Resistant |
| ENSG00000224272.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.013234677 |
Resistant |
| ENSG00000224478.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.028705279 |
Resistant |
| ENSG00000224883.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.020069986 |
Resistant |
| ENSG00000224973.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027892253 |
Resistant |
| ENSG00000225180.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006413102 |
Resistant |
| ENSG00000225742.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046932025 |
Resistant |
| ENSG00000225891.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033205313 |
Resistant |
| ENSG00000226363.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025327552 |
Resistant |
| ENSG00000226645.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003664939 |
Resistant |
| ENSG00000226648.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.038668094 |
Resistant |
| ENSG00000226709.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.008807159 |
Resistant |
| ENSG00000226751.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025758006 |
Resistant |
| ENSG00000226780.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04383919 |
Resistant |
| ENSG00000226853.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.017160337 |
Resistant |
| ENSG00000226899.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03094331 |
Resistant |
| ENSG00000227050.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021997655 |
Resistant |
| ENSG00000227374.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027117054 |
Resistant |
| ENSG00000227811.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006925406 |
Resistant |
| ENSG00000227906.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.022947509 |
Resistant |
| ENSG00000228016.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049657295 |
Resistant |
| ENSG00000228135.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.030422449 |
Resistant |
| ENSG00000228251.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04846322 |
Resistant |
| ENSG00000228293.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.008533737 |
Resistant |
| ENSG00000228719.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015981624 |
Resistant |
| ENSG00000228794.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006856636 |
Resistant |
| ENSG00000229770.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049802577 |
Resistant |
| ENSG00000230126.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.004819782 |
Resistant |
| ENSG00000230454.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.041084518 |
Resistant |
| ENSG00000230506.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04655802 |
Resistant |
| ENSG00000230676.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006204204 |
Resistant |
| ENSG00000230735.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.029117746 |
Resistant |
| ENSG00000230736.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.041912604 |
Resistant |
| ENSG00000231305.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037605483 |
Resistant |
| ENSG00000231473.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.028224839 |
Resistant |
| ENSG00000231485.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046027219 |
Resistant |
| ENSG00000231636.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023143188 |
Resistant |
| ENSG00000231789.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.000259031 |
Resistant |
| ENSG00000231840.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03598322 |
Resistant |
| ENSG00000232160.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003410801 |
Resistant |
| ENSG00000232197.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037802547 |
Resistant |
| ENSG00000232352.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.014221641 |
Resistant |
| ENSG00000232611.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033866861 |
Resistant |
| ENSG00000232732.5 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049692807 |
Resistant |
| ENSG00000233038.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.00290467 |
Resistant |
| ENSG00000233757.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.008669541 |
Resistant |
| ENSG00000233806.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049860169 |
Resistant |
| ENSG00000234160.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009760324 |
Resistant |
| ENSG00000234206.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.017907519 |
Resistant |
| ENSG00000234848.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.019384732 |
Resistant |
| ENSG00000234917.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021140437 |
Resistant |
| ENSG00000234921.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026237768 |
Resistant |
| ENSG00000235024.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026131343 |
Resistant |
| ENSG00000235185.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045317626 |
Resistant |
| ENSG00000235526.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025553355 |
Resistant |
| ENSG00000235601.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025797258 |
Resistant |
| ENSG00000235643.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.007466701 |
Resistant |
| ENSG00000235665.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.013074051 |
Resistant |
| ENSG00000235740.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015524386 |
Resistant |
| ENSG00000235872.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026786338 |
Resistant |
| ENSG00000236545.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037186792 |
Resistant |
| ENSG00000236651.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021303226 |
Resistant |
| ENSG00000236901.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.034737125 |
Resistant |
| ENSG00000237248.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.029686855 |
Resistant |
| ENSG00000237380.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009998229 |
Resistant |
| ENSG00000237436.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009653564 |
Resistant |
| ENSG00000237438.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.018270312 |
Resistant |
| ENSG00000237517.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.016320749 |
Resistant |
| ENSG00000238197.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.041501436 |
Resistant |
| ENSG00000239335.4 |
Cyclopamine |
Lung squamous cell carcinoma |
0.024833267 |
Resistant |
| ENSG00000239608.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.002394935 |
Resistant |
| ENSG00000240086.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.035719095 |
Resistant |
| ENSG00000242078.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.022998166 |
Resistant |
| ENSG00000242082.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04332207 |
Resistant |
| ENSG00000242104.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015677981 |
Resistant |
| ENSG00000245729.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015167382 |
Resistant |
| ENSG00000248256.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015967023 |
Resistant |
| ENSG00000248668.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.041683943 |
Resistant |
| ENSG00000248774.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.01574726 |
Resistant |
| ENSG00000249159.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042570634 |
Resistant |
| ENSG00000250433.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049955802 |
Resistant |
| ENSG00000251497.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042870894 |
Resistant |
| ENSG00000253308.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.038046238 |
Resistant |
| ENSG00000253392.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.024575983 |
Resistant |
| ENSG00000253563.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.040942859 |
Resistant |
| ENSG00000253596.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.047919038 |
Resistant |
| ENSG00000253704.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.044879799 |
Resistant |
| ENSG00000253730.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033907035 |
Resistant |
| ENSG00000254427.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.019410855 |
Resistant |
| ENSG00000255027.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.018994256 |
Resistant |
| ENSG00000255129.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027156853 |
Resistant |
| ENSG00000255310.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045236952 |
Resistant |
| ENSG00000255366.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021228078 |
Resistant |
| ENSG00000255409.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03317217 |
Resistant |
| ENSG00000256008.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023707499 |
Resistant |
| ENSG00000256458.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.005158602 |
Resistant |
| ENSG00000256596.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027380063 |
Resistant |
| ENSG00000256742.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.006710908 |
Resistant |
| ENSG00000257151.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.036511167 |
Resistant |
| ENSG00000257272.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.036220308 |
Resistant |
| ENSG00000257647.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.039626628 |
Resistant |
| ENSG00000258301.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.034460477 |
Resistant |
| ENSG00000258515.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.018672999 |
Resistant |
| ENSG00000258673.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.00923978 |
Resistant |
| ENSG00000259212.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.019322591 |
Resistant |
| ENSG00000259218.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037646759 |
Resistant |
| ENSG00000259485.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023362296 |
Resistant |
| ENSG00000259664.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.032372787 |
Resistant |
| ENSG00000259723.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023395012 |
Resistant |
| ENSG00000259792.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045636067 |
Resistant |
| ENSG00000259834.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.044968606 |
Resistant |
| ENSG00000259881.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025236107 |
Resistant |
| ENSG00000259959.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.010904156 |
Resistant |
| ENSG00000260063.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.030893321 |
Resistant |
| ENSG00000260065.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.019744273 |
Resistant |
| ENSG00000260583.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045933071 |
Resistant |
| ENSG00000260655.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009778842 |
Resistant |
| ENSG00000260831.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.01432468 |
Resistant |
| ENSG00000260931.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.024181658 |
Resistant |
| ENSG00000261002.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048413217 |
Resistant |
| ENSG00000261096.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042254941 |
Resistant |
| ENSG00000261159.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045473015 |
Resistant |
| ENSG00000261342.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.044683689 |
Resistant |
| ENSG00000261478.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045063201 |
Resistant |
| ENSG00000261695.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023683575 |
Resistant |
| ENSG00000261839.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.022792241 |
Resistant |
| ENSG00000262119.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048507064 |
Resistant |
| ENSG00000262772.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.00587918 |
Resistant |
| ENSG00000263080.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037489507 |
Resistant |
| ENSG00000263731.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.020104498 |
Resistant |
| ENSG00000263859.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015151849 |
Resistant |
| ENSG00000263906.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.007328094 |
Resistant |
| ENSG00000265008.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003337065 |
Resistant |
| ENSG00000265242.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.005360785 |
Resistant |
| ENSG00000265342.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045618167 |
Resistant |
| ENSG00000266256.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.005746789 |
Resistant |
| ENSG00000266579.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.043440225 |
Resistant |
| ENSG00000266912.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037566166 |
Resistant |
| ENSG00000267034.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025814559 |
Resistant |
| ENSG00000267254.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009814141 |
Resistant |
| ENSG00000267388.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026700978 |
Resistant |
| ENSG00000267480.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026799053 |
Resistant |
| ENSG00000267785.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048436985 |
Resistant |
| ENSG00000267868.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048897395 |
Resistant |
| ENSG00000267940.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003476901 |
Resistant |
| ENSG00000269524.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049955288 |
Resistant |
| ENSG00000269752.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026586971 |
Resistant |
| ENSG00000269918.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.02077019 |
Resistant |
| ENSG00000269923.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027557926 |
Resistant |
| ENSG00000269949.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.004266576 |
Resistant |
| ENSG00000270018.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.010579167 |
Resistant |
| ENSG00000270189.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.027463651 |
Resistant |
| ENSG00000270223.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021986721 |
Resistant |
| ENSG00000270557.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04369344 |
Resistant |
| ENSG00000271086.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048808262 |
Resistant |
| ENSG00000271119.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033769882 |
Resistant |
| ENSG00000271314.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.005519525 |
Resistant |
| ENSG00000271914.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.008263903 |
Resistant |
| ENSG00000271981.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033034719 |
Resistant |
| ENSG00000272004.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.038958259 |
Resistant |
| ENSG00000272077.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.029673716 |
Resistant |
| ENSG00000272087.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.013935022 |
Resistant |
| ENSG00000272275.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03667586 |
Resistant |
| ENSG00000272375.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.016490071 |
Resistant |
| ENSG00000272379.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04555826 |
Resistant |
| ENSG00000272440.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.007058009 |
Resistant |
| ENSG00000272520.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.005672873 |
Resistant |
| ENSG00000272644.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048422188 |
Resistant |
| ENSG00000272682.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023670531 |
Resistant |
| ENSG00000272702.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.041310262 |
Resistant |
| ENSG00000272707.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.012016405 |
Resistant |
| ENSG00000272777.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03406536 |
Resistant |
| ENSG00000272904.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.016592158 |
Resistant |
| ENSG00000272912.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.040555382 |
Resistant |
| ENSG00000272966.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.021154095 |
Resistant |
| ENSG00000272971.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046102566 |
Resistant |
| ENSG00000273081.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003106874 |
Resistant |
| ENSG00000273293.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042483934 |
Resistant |
| ENSG00000273325.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042214383 |
Resistant |
| ENSG00000273343.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046190585 |
Resistant |
| ENSG00000273365.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.000878846 |
Resistant |
| ENSG00000273373.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.016714482 |
Resistant |
| ENSG00000273442.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037800121 |
Resistant |
| ENSG00000273456.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.026542718 |
Resistant |
| ENSG00000273473.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.009046649 |
Resistant |
| ENSG00000171889.3 |
Cyclopamine |
Breast invasive carcinoma |
0.036394141 |
Sensitive |
| ENSG00000174171.4 |
Cyclopamine |
Breast invasive carcinoma |
0.028578278 |
Sensitive |
| ENSG00000175147.7 |
Cyclopamine |
Breast invasive carcinoma |
0.010715709 |
Sensitive |
| ENSG00000178412.4 |
Cyclopamine |
Breast invasive carcinoma |
0.016443128 |
Sensitive |
| ENSG00000182648.7 |
Cyclopamine |
Breast invasive carcinoma |
0.029812792 |
Sensitive |
| ENSG00000206195.6 |
Cyclopamine |
Breast invasive carcinoma |
0.042037552 |
Sensitive |
| ENSG00000215304.3 |
Cyclopamine |
Breast invasive carcinoma |
0.017893092 |
Sensitive |
| ENSG00000223546.2 |
Cyclopamine |
Breast invasive carcinoma |
0.048205425 |
Sensitive |
| ENSG00000223784.1 |
Cyclopamine |
Breast invasive carcinoma |
0.009769381 |
Sensitive |
| ENSG00000224020.1 |
Cyclopamine |
Breast invasive carcinoma |
0.031986744 |
Sensitive |
| ENSG00000224271.1 |
Cyclopamine |
Breast invasive carcinoma |
0.034091835 |
Sensitive |
| ENSG00000226465.1 |
Cyclopamine |
Breast invasive carcinoma |
0.029256448 |
Sensitive |
| ENSG00000231407.1 |
Cyclopamine |
Breast invasive carcinoma |
0.041688756 |
Sensitive |
| ENSG00000231711.2 |
Cyclopamine |
Breast invasive carcinoma |
0.049247918 |
Sensitive |
| ENSG00000234880.1 |
Cyclopamine |
Breast invasive carcinoma |
0.000921289 |
Sensitive |
| ENSG00000236377.1 |
Cyclopamine |
Breast invasive carcinoma |
0.01471914 |
Sensitive |
| ENSG00000237781.2 |
Cyclopamine |
Breast invasive carcinoma |
0.017952229 |
Sensitive |
| ENSG00000237819.1 |
Cyclopamine |
Breast invasive carcinoma |
0.013516776 |
Sensitive |
| ENSG00000242242.1 |
Cyclopamine |
Breast invasive carcinoma |
0.013758672 |
Sensitive |
| ENSG00000242516.1 |
Cyclopamine |
Breast invasive carcinoma |
0.030742527 |
Sensitive |
| ENSG00000242791.2 |
Cyclopamine |
Breast invasive carcinoma |
0.002786674 |
Sensitive |
| ENSG00000244306.5 |
Cyclopamine |
Breast invasive carcinoma |
0.04949538 |
Sensitive |
| ENSG00000250899.3 |
Cyclopamine |
Breast invasive carcinoma |
0.031176737 |
Sensitive |
| ENSG00000251161.2 |
Cyclopamine |
Breast invasive carcinoma |
0.034774113 |
Sensitive |
| ENSG00000253112.1 |
Cyclopamine |
Breast invasive carcinoma |
0.028327403 |
Sensitive |
| ENSG00000255139.1 |
Cyclopamine |
Breast invasive carcinoma |
0.023344986 |
Sensitive |
| ENSG00000255236.2 |
Cyclopamine |
Breast invasive carcinoma |
0.006495144 |
Sensitive |
| ENSG00000256448.1 |
Cyclopamine |
Breast invasive carcinoma |
0.030604375 |
Sensitive |
| ENSG00000257556.1 |
Cyclopamine |
Breast invasive carcinoma |
0.016617797 |
Sensitive |
| ENSG00000259005.1 |
Cyclopamine |
Breast invasive carcinoma |
0.019971136 |
Sensitive |
| ENSG00000259250.1 |
Cyclopamine |
Breast invasive carcinoma |
0.023300841 |
Sensitive |
| ENSG00000259732.1 |
Cyclopamine |
Breast invasive carcinoma |
0.037814662 |
Sensitive |
| ENSG00000261386.2 |
Cyclopamine |
Breast invasive carcinoma |
0.048442038 |
Sensitive |
| ENSG00000262434.1 |
Cyclopamine |
Breast invasive carcinoma |
0.027125354 |
Sensitive |
| ENSG00000262714.1 |
Cyclopamine |
Breast invasive carcinoma |
0.042877496 |
Sensitive |
| ENSG00000263847.1 |
Cyclopamine |
Breast invasive carcinoma |
0.047777954 |
Sensitive |
| ENSG00000265091.1 |
Cyclopamine |
Breast invasive carcinoma |
0.035898885 |
Sensitive |
| ENSG00000266947.1 |
Cyclopamine |
Breast invasive carcinoma |
0.019701666 |
Sensitive |
| ENSG00000267213.3 |
Cyclopamine |
Breast invasive carcinoma |
0.047693692 |
Sensitive |
| ENSG00000267322.1 |
Cyclopamine |
Breast invasive carcinoma |
0.021867607 |
Sensitive |
| ENSG00000268119.1 |
Cyclopamine |
Breast invasive carcinoma |
0.015562537 |
Sensitive |
| ENSG00000271659.1 |
Cyclopamine |
Breast invasive carcinoma |
0.001254717 |
Sensitive |
| ENSG00000271889.1 |
Cyclopamine |
Breast invasive carcinoma |
0.013575953 |
Sensitive |
| ENSG00000272070.1 |
Cyclopamine |
Breast invasive carcinoma |
0.036222798 |
Sensitive |
| ENSG00000272076.1 |
Cyclopamine |
Breast invasive carcinoma |
0.03763372 |
Sensitive |
| ENSG00000272138.1 |
Cyclopamine |
Breast invasive carcinoma |
0.020069145 |
Sensitive |
| ENSG00000273230.1 |
Cyclopamine |
Breast invasive carcinoma |
0.045002812 |
Sensitive |
| ENSG00000126005.11 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005142371 |
Sensitive |
| ENSG00000188825.9 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042611432 |
Sensitive |
| ENSG00000203875.6 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015253455 |
Sensitive |
| ENSG00000204837.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010018103 |
Sensitive |
| ENSG00000214719.7 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027871081 |
Sensitive |
| ENSG00000215256.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004439846 |
Sensitive |
| ENSG00000223754.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016425256 |
Sensitive |
| ENSG00000224509.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019969427 |
Sensitive |
| ENSG00000224699.4 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043612803 |
Sensitive |
| ENSG00000225138.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01010306 |
Sensitive |
| ENSG00000225760.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018750117 |
Sensitive |
| ENSG00000225964.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001523715 |
Sensitive |
| ENSG00000226824.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037065503 |
Sensitive |
| ENSG00000227237.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039682162 |
Sensitive |
| ENSG00000227518.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024300984 |
Sensitive |
| ENSG00000229137.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031710124 |
Sensitive |
| ENSG00000229539.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048333535 |
Sensitive |
| ENSG00000231131.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021605983 |
Sensitive |
| ENSG00000231212.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025453893 |
Sensitive |
| ENSG00000231563.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009003998 |
Sensitive |
| ENSG00000231663.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049187678 |
Sensitive |
| ENSG00000232618.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042068374 |
Sensitive |
| ENSG00000233893.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016286626 |
Sensitive |
| ENSG00000234174.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000605027 |
Sensitive |
| ENSG00000234181.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040408431 |
Sensitive |
| ENSG00000234183.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029069197 |
Sensitive |
| ENSG00000234945.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040081828 |
Sensitive |
| ENSG00000235106.4 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028417003 |
Sensitive |
| ENSG00000235314.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035207029 |
Sensitive |
| ENSG00000235908.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02632959 |
Sensitive |
| ENSG00000240005.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0198361 |
Sensitive |
| ENSG00000240859.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00690341 |
Sensitive |
| ENSG00000248367.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002192445 |
Sensitive |
| ENSG00000248936.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011415699 |
Sensitive |
| ENSG00000249207.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004654717 |
Sensitive |
| ENSG00000249684.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041349424 |
Sensitive |
| ENSG00000250061.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000825257 |
Sensitive |
| ENSG00000250062.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014045362 |
Sensitive |
| ENSG00000250899.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048457705 |
Sensitive |
| ENSG00000250900.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046248444 |
Sensitive |
| ENSG00000253552.3 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002466532 |
Sensitive |
| ENSG00000253696.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004087886 |
Sensitive |
| ENSG00000256250.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000524421 |
Sensitive |
| ENSG00000256299.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014860134 |
Sensitive |
| ENSG00000257086.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046203291 |
Sensitive |
| ENSG00000257283.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021225091 |
Sensitive |
| ENSG00000260038.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039424955 |
Sensitive |
| ENSG00000260774.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002228416 |
Sensitive |
| ENSG00000261186.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048514774 |
Sensitive |
| ENSG00000261188.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048041696 |
Sensitive |
| ENSG00000261251.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005595563 |
Sensitive |
| ENSG00000262155.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00023985 |
Sensitive |
| ENSG00000267505.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011245494 |
Sensitive |
| ENSG00000268001.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00880934 |
Sensitive |
| ENSG00000268366.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040554344 |
Sensitive |
| ENSG00000268499.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013150172 |
Sensitive |
| ENSG00000268573.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048090808 |
Sensitive |
| ENSG00000269392.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040727238 |
Sensitive |
| ENSG00000269600.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023316208 |
Sensitive |
| ENSG00000269911.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033314984 |
Sensitive |
| ENSG00000269966.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03141502 |
Sensitive |
| ENSG00000270127.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039117633 |
Sensitive |
| ENSG00000270133.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007544149 |
Sensitive |
| ENSG00000270332.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013621398 |
Sensitive |
| ENSG00000270362.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037816963 |
Sensitive |
| ENSG00000271757.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035779913 |
Sensitive |
| ENSG00000272221.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036161223 |
Sensitive |
| ENSG00000272226.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047930116 |
Sensitive |
| ENSG00000272462.2 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036759114 |
Sensitive |
| ENSG00000272716.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003224865 |
Sensitive |
| ENSG00000272864.1 |
Cyclopamine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041778215 |
Sensitive |
| ENSG00000179743.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.046323958 |
Sensitive |
| ENSG00000205959.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.044327317 |
Sensitive |
| ENSG00000213971.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.028759442 |
Sensitive |
| ENSG00000223552.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.034357822 |
Sensitive |
| ENSG00000223573.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019398611 |
Sensitive |
| ENSG00000223774.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.006051569 |
Sensitive |
| ENSG00000225527.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.03488808 |
Sensitive |
| ENSG00000225579.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.032946593 |
Sensitive |
| ENSG00000229776.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.027575408 |
Sensitive |
| ENSG00000230005.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040202032 |
Sensitive |
| ENSG00000231312.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.006343545 |
Sensitive |
| ENSG00000232876.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.010478479 |
Sensitive |
| ENSG00000233296.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.042157293 |
Sensitive |
| ENSG00000235802.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.035663249 |
Sensitive |
| ENSG00000236066.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.042721566 |
Sensitive |
| ENSG00000246174.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.014893351 |
Sensitive |
| ENSG00000246985.3 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040373458 |
Sensitive |
| ENSG00000248559.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.017770484 |
Sensitive |
| ENSG00000248668.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.026625823 |
Sensitive |
| ENSG00000249815.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.04601327 |
Sensitive |
| ENSG00000250312.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.045152746 |
Sensitive |
| ENSG00000251323.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.016316266 |
Sensitive |
| ENSG00000251497.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.013532017 |
Sensitive |
| ENSG00000251867.2 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.034637365 |
Sensitive |
| ENSG00000254129.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.033104921 |
Sensitive |
| ENSG00000254495.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.0474748 |
Sensitive |
| ENSG00000254539.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.004385502 |
Sensitive |
| ENSG00000257272.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.049265665 |
Sensitive |
| ENSG00000257449.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.045921768 |
Sensitive |
| ENSG00000257507.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.03124253 |
Sensitive |
| ENSG00000258451.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.046470744 |
Sensitive |
| ENSG00000259065.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.028821697 |
Sensitive |
| ENSG00000259520.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.028504521 |
Sensitive |
| ENSG00000260022.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.032820326 |
Sensitive |
| ENSG00000260296.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.010542802 |
Sensitive |
| ENSG00000260464.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.01054095 |
Sensitive |
| ENSG00000260949.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.037573445 |
Sensitive |
| ENSG00000261207.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040488833 |
Sensitive |
| ENSG00000261318.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.024527586 |
Sensitive |
| ENSG00000261839.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.036020137 |
Sensitive |
| ENSG00000263220.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.044709379 |
Sensitive |
| ENSG00000266289.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.027115287 |
Sensitive |
| ENSG00000267093.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.016760388 |
Sensitive |
| ENSG00000267612.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.044822341 |
Sensitive |
| ENSG00000268458.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.005426523 |
Sensitive |
| ENSG00000269054.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.044572713 |
Sensitive |
| ENSG00000269947.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.041111067 |
Sensitive |
| ENSG00000270040.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019135189 |
Sensitive |
| ENSG00000270557.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.04602887 |
Sensitive |
| ENSG00000270580.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.018996026 |
Sensitive |
| ENSG00000270828.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.040660198 |
Sensitive |
| ENSG00000271382.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.01477256 |
Sensitive |
| ENSG00000271869.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.02472284 |
Sensitive |
| ENSG00000271971.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.024018703 |
Sensitive |
| ENSG00000271993.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.038921364 |
Sensitive |
| ENSG00000272301.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.014260982 |
Sensitive |
| ENSG00000272373.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.019846825 |
Sensitive |
| ENSG00000272791.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.005197901 |
Sensitive |
| ENSG00000273176.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.028793393 |
Sensitive |
| ENSG00000273355.1 |
Cyclopamine |
Chronic Lymphocytic Leukemia |
0.033094088 |
Sensitive |
| ENSG00000187229.3 |
Cyclopamine |
Brain lower grade glioma |
0.047252984 |
Sensitive |
| ENSG00000196972.6 |
Cyclopamine |
Brain lower grade glioma |
0.047663416 |
Sensitive |
| ENSG00000223635.1 |
Cyclopamine |
Brain lower grade glioma |
0.045343834 |
Sensitive |
| ENSG00000223759.2 |
Cyclopamine |
Brain lower grade glioma |
0.003647448 |
Sensitive |
| ENSG00000223855.1 |
Cyclopamine |
Brain lower grade glioma |
0.045813456 |
Sensitive |
| ENSG00000224216.1 |
Cyclopamine |
Brain lower grade glioma |
0.014626814 |
Sensitive |
| ENSG00000225177.1 |
Cyclopamine |
Brain lower grade glioma |
0.039192571 |
Sensitive |
| ENSG00000226067.2 |
Cyclopamine |
Brain lower grade glioma |
0.007056723 |
Sensitive |
| ENSG00000226203.1 |
Cyclopamine |
Brain lower grade glioma |
0.042044766 |
Sensitive |
| ENSG00000227036.2 |
Cyclopamine |
Brain lower grade glioma |
0.020756862 |
Sensitive |
| ENSG00000227279.1 |
Cyclopamine |
Brain lower grade glioma |
0.02997185 |
Sensitive |
| ENSG00000228028.2 |
Cyclopamine |
Brain lower grade glioma |
0.0262859 |
Sensitive |
| ENSG00000229688.3 |
Cyclopamine |
Brain lower grade glioma |
0.0463795 |
Sensitive |
| ENSG00000230798.1 |
Cyclopamine |
Brain lower grade glioma |
0.031540222 |
Sensitive |
| ENSG00000231187.2 |
Cyclopamine |
Brain lower grade glioma |
0.043429369 |
Sensitive |
| ENSG00000231729.1 |
Cyclopamine |
Brain lower grade glioma |
0.003620946 |
Sensitive |
| ENSG00000235358.1 |
Cyclopamine |
Brain lower grade glioma |
0.048875353 |
Sensitive |
| ENSG00000235423.4 |
Cyclopamine |
Brain lower grade glioma |
0.014252757 |
Sensitive |
| ENSG00000235999.1 |
Cyclopamine |
Brain lower grade glioma |
0.005675367 |
Sensitive |
| ENSG00000236166.1 |
Cyclopamine |
Brain lower grade glioma |
0.009171352 |
Sensitive |
| ENSG00000236230.1 |
Cyclopamine |
Brain lower grade glioma |
0.015481136 |
Sensitive |
| ENSG00000236772.1 |
Cyclopamine |
Brain lower grade glioma |
0.042729847 |
Sensitive |
| ENSG00000239705.1 |
Cyclopamine |
Brain lower grade glioma |
0.006214291 |
Sensitive |
| ENSG00000241818.1 |
Cyclopamine |
Brain lower grade glioma |
0.014885234 |
Sensitive |
| ENSG00000244203.2 |
Cyclopamine |
Brain lower grade glioma |
0.016824754 |
Sensitive |
| ENSG00000250320.1 |
Cyclopamine |
Brain lower grade glioma |
0.021705986 |
Sensitive |
| ENSG00000251661.3 |
Cyclopamine |
Brain lower grade glioma |
0.027338193 |
Sensitive |
| ENSG00000253819.1 |
Cyclopamine |
Brain lower grade glioma |
0.01547511 |
Sensitive |
| ENSG00000254389.2 |
Cyclopamine |
Brain lower grade glioma |
0.021282449 |
Sensitive |
| ENSG00000255089.1 |
Cyclopamine |
Brain lower grade glioma |
0.012610322 |
Sensitive |
| ENSG00000255446.1 |
Cyclopamine |
Brain lower grade glioma |
0.042042895 |
Sensitive |
| ENSG00000255557.1 |
Cyclopamine |
Brain lower grade glioma |
0.027618525 |
Sensitive |
| ENSG00000259705.1 |
Cyclopamine |
Brain lower grade glioma |
0.006989757 |
Sensitive |
| ENSG00000259755.1 |
Cyclopamine |
Brain lower grade glioma |
0.007640175 |
Sensitive |
| ENSG00000260336.1 |
Cyclopamine |
Brain lower grade glioma |
0.03395141 |
Sensitive |
| ENSG00000260578.1 |
Cyclopamine |
Brain lower grade glioma |
0.028578785 |
Sensitive |
| ENSG00000260693.1 |
Cyclopamine |
Brain lower grade glioma |
0.007083661 |
Sensitive |
| ENSG00000261064.1 |
Cyclopamine |
Brain lower grade glioma |
0.005560342 |
Sensitive |
| ENSG00000261971.2 |
Cyclopamine |
Brain lower grade glioma |
0.049849035 |
Sensitive |
| ENSG00000262482.1 |
Cyclopamine |
Brain lower grade glioma |
0.019925664 |
Sensitive |
| ENSG00000263466.1 |
Cyclopamine |
Brain lower grade glioma |
0.023831816 |
Sensitive |
| ENSG00000263680.2 |
Cyclopamine |
Brain lower grade glioma |
0.027616582 |
Sensitive |
| ENSG00000264339.1 |
Cyclopamine |
Brain lower grade glioma |
0.044684668 |
Sensitive |
| ENSG00000264635.1 |
Cyclopamine |
Brain lower grade glioma |
0.047609448 |
Sensitive |
| ENSG00000267082.1 |
Cyclopamine |
Brain lower grade glioma |
0.021919363 |
Sensitive |
| ENSG00000267547.1 |
Cyclopamine |
Brain lower grade glioma |
0.017989419 |
Sensitive |
| ENSG00000267745.1 |
Cyclopamine |
Brain lower grade glioma |
0.036193153 |
Sensitive |
| ENSG00000270105.1 |
Cyclopamine |
Brain lower grade glioma |
0.008165748 |
Sensitive |
| ENSG00000271631.1 |
Cyclopamine |
Brain lower grade glioma |
0.004586744 |
Sensitive |
| ENSG00000271857.1 |
Cyclopamine |
Brain lower grade glioma |
0.035538015 |
Sensitive |
| ENSG00000271897.1 |
Cyclopamine |
Brain lower grade glioma |
0.027502016 |
Sensitive |
| ENSG00000272065.1 |
Cyclopamine |
Brain lower grade glioma |
0.026995917 |
Sensitive |
| ENSG00000272782.1 |
Cyclopamine |
Brain lower grade glioma |
0.021013791 |
Sensitive |
| ENSG00000223946.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.048068669 |
Sensitive |
| ENSG00000224884.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.02223486 |
Sensitive |
| ENSG00000225703.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.045049882 |
Sensitive |
| ENSG00000225778.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.024430256 |
Sensitive |
| ENSG00000227200.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.023001284 |
Sensitive |
| ENSG00000227844.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.031094058 |
Sensitive |
| ENSG00000228536.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.012679865 |
Sensitive |
| ENSG00000228614.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.031154509 |
Sensitive |
| ENSG00000229118.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.036998511 |
Sensitive |
| ENSG00000229160.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.012300613 |
Sensitive |
| ENSG00000229621.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.030150852 |
Sensitive |
| ENSG00000231663.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.015888814 |
Sensitive |
| ENSG00000231721.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.03371137 |
Sensitive |
| ENSG00000232480.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042465088 |
Sensitive |
| ENSG00000233554.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.034131766 |
Sensitive |
| ENSG00000234705.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.028847313 |
Sensitive |
| ENSG00000234707.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04513785 |
Sensitive |
| ENSG00000240032.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.032180658 |
Sensitive |
| ENSG00000243179.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025313647 |
Sensitive |
| ENSG00000246394.3 |
Cyclopamine |
Lung squamous cell carcinoma |
0.00019599 |
Sensitive |
| ENSG00000247624.2 |
Cyclopamine |
Lung squamous cell carcinoma |
0.022884461 |
Sensitive |
| ENSG00000248125.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.022174528 |
Sensitive |
| ENSG00000248494.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.01887928 |
Sensitive |
| ENSG00000248758.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.017208981 |
Sensitive |
| ENSG00000250240.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.011713973 |
Sensitive |
| ENSG00000250320.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.036680507 |
Sensitive |
| ENSG00000250602.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.028385366 |
Sensitive |
| ENSG00000251292.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.044695806 |
Sensitive |
| ENSG00000251504.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.042289426 |
Sensitive |
| ENSG00000254109.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.035318619 |
Sensitive |
| ENSG00000254248.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.033648661 |
Sensitive |
| ENSG00000254486.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046908807 |
Sensitive |
| ENSG00000256001.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.030690931 |
Sensitive |
| ENSG00000257023.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.044016996 |
Sensitive |
| ENSG00000257845.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.01807722 |
Sensitive |
| ENSG00000258355.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.00738226 |
Sensitive |
| ENSG00000260368.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.004546597 |
Sensitive |
| ENSG00000260378.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.049885497 |
Sensitive |
| ENSG00000261632.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.025346057 |
Sensitive |
| ENSG00000261662.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04898002 |
Sensitive |
| ENSG00000262370.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.019680808 |
Sensitive |
| ENSG00000265992.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.043782176 |
Sensitive |
| ENSG00000267003.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.008130381 |
Sensitive |
| ENSG00000267279.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046465991 |
Sensitive |
| ENSG00000268366.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.046241222 |
Sensitive |
| ENSG00000269481.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.038066324 |
Sensitive |
| ENSG00000269640.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04940151 |
Sensitive |
| ENSG00000272070.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.04570131 |
Sensitive |
| ENSG00000272183.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.037494132 |
Sensitive |
| ENSG00000272709.1 |
Cyclopamine |
Lung squamous cell carcinoma |
0.003505038 |
Sensitive |
